Amazentis competitive analysis

Explore patent oppositions filed by Amazentis against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition Date
Urolithin A And A Composition Containing Same For External Use In Inflammations Of Various EtiologiesMICROBIOTA MED SP Z OOOct 15, 2025

Explore Amazentis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Feb 12, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 12, 2025Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive Disorders2
Mar 12, 2025Compositions And Methods For Improving Mitochondrial Function And Treating Neurodegenerative Diseases And Cognitive Disorders1

Latest PTAB cases involving Amazentis

Discover the latest PTAB cases involving Amazentis, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Amazentis with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 12, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMAZENTIS13 - -
J A KEMP44 - - -
MICROBIOTA MED SP Z OO21 - -
WARSZAWSKI UNIWERSYTET MEDYCZNY - 1 - -